Liquidia Corporation
$55.69
+1.5%Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
Medium confidenceValuation multiple is compressed (P/E -69.6).
Valuation inputs: P/E -69.6, earnings yield N/A, momentum +1.5%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is soft (ROE -1.5%, ROIC -20.5%).
Profitability stack: net margin -43.5%, ROE -1.5%, ROIC -20.5%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceDownside profile is elevated and scenario stress-testing is essential.
Risk factors: liabilities/assets +86.4%, momentum +1.5%, net margin -43.5%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
Liquidia Corporation Market vs Earnings Trajectory
Loading price and EPS data...
Liquidia Corporation Fair Value Envelope
Liquidia Corporation Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Liquidia Corporation Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Weak cash conversion. Significant portion of earnings not converting to cash—review working capital trends and capital intensity.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extension—monitor closely.
Cash Flow Quality Insight
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
Liquidia Corporation Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.
Debt-to-Equity Ratio
High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Balanced asset mix between current and non-current assets, typical of many stable businesses.
Liquidia Corporation Street Expectations Map
Wall Street analysts project that LQDA stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 63.00, with estimates ranging from a low of 60.00 to a high of 67.00.
The consensus 1-year price target stands at 63.00, with estimates ranging from a low of 60.00 to a high of 67.00.
Analyst Consensus Analysis
Upside Potential
Moderate upside. Analysts expect positive returns but with limited margin of safety. Consider entry timing.
Analyst Agreement
High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.
Analyst Conviction
Positive outlook with reasonable agreement. Analysts generally optimistic about prospects with manageable uncertainty.
Market Sentiment Insight
Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.
Liquidia Corporation Insider Positioning
During the last 12 months, insiders have purchased $318K and sold $73.98M worth of LQDA shares, resulting in $73.67M of net selling activity.
3 Months
5.3K
317.89K
934.8K
41.44M
-41.1M
-$41.12M
3-6 Months
0
0.00
217.0K
8.10M
-8.1M
-$8.10M
6-9 Months
0
0.00
230.9K
6.06M
-6.1M
-$6.06M
9-12 Months
0
0.00
722.2K
18.38M
-18.4M
-$18.38M
Top Buyers
Caligan Partners Lp
Director, 10 Percent Owner, Other: See Remarks
$318K
Top Sellers
Jeffs Roger
Director, Officer: Chief Executive Officer
$23.48M
Kaseta Michael
Officer: Cfo And Coo
$12.30M
Manning Paul B
Director
$11.67M
Moomaw Scott
Officer: Chief Commercial Officer
$6.10M
Bloch Stephen M
Director
$5.05M
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $73.67M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
No Dividend Yield Data
LQDA has not reported any dividend yield values in the available annual periods.
lqda Dividend History
Learning Layer
Related Guides
Build conviction on LQDA by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.